135 related articles for article (PubMed ID: 6717166)
21. Role of acyclovir gel in herpes simplex: clinical implications.
Seth AK; Misra A; Umrigar D; Vora N
Med Sci Monit; 2003 Jul; 9(7):PI93-8. PubMed ID: 12883465
[TBL] [Abstract][Full Text] [Related]
22. Effect of immunization with herpes simplex virus type-1 (HSV-1) glycoprotein D (gD) plus the immune enhancer GPI-0100 on infection with HSV-1 or HSV-2.
Quenelle DC; Collins DJ; Marciani DJ; Kern ER
Vaccine; 2006 Mar; 24(10):1515-22. PubMed ID: 16288820
[TBL] [Abstract][Full Text] [Related]
23. Iontophoretic application of adenine arabinoside monophosphate for the treatment of herpes simplex virus type 2 skin infections in hairless mice.
Kwon BS; Hill JM; Wiggins C; Tuggle C
J Infect Dis; 1979 Dec; 140(6):1014. PubMed ID: 94335
[No Abstract] [Full Text] [Related]
24. Topical treatment of cutaneous herpes simplex virus infection in hairless mice with (E)-5-(2-bromovinyl)-2'-deoxyuridine and related compounds.
de Clercq E
Antimicrob Agents Chemother; 1984 Aug; 26(2):155-9. PubMed ID: 6486759
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of phosphonylmethoxyalkyl derivatives of adenine in experimental herpes simplex virus and vaccinia virus infections in vivo.
De Clercq E; Holý A; Rosenberg I
Antimicrob Agents Chemother; 1989 Feb; 33(2):185-91. PubMed ID: 2719463
[TBL] [Abstract][Full Text] [Related]
26. The efficacy of antiviral antibiotic 17997 on treatment of HSV-1 infected guinea pig skin infection.
Tao P; Wang S; Leng Q
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Jun; 14(2):125-7. PubMed ID: 11503040
[TBL] [Abstract][Full Text] [Related]
27. Topical application of penciclovir cream for the treatment of herpes simplex facialis/labialis: a randomized, double-blind, multicentre, aciclovir-controlled trial.
Lin L; Chen XS; Cui PG; Wang JB; Guo ZP; Lu NZ; Bi ZG; Jia H; Yang XY;
J Dermatolog Treat; 2002 Jun; 13(2):67-72. PubMed ID: 12060504
[TBL] [Abstract][Full Text] [Related]
28. Effect of treatment with 1-beta-D-arabinofuranosylthymine of experimental encephalitis induced by herpes simplex virus in mice.
Machida H; Ichikawa M; Kuninaka A; Saneyoshi M; Yoshino H
Antimicrob Agents Chemother; 1980 Feb; 17(2):109-14. PubMed ID: 7387135
[TBL] [Abstract][Full Text] [Related]
29. Immunomodulatory roles of topical dinitrochlorobenzene treatment in Herpes simplex virus infection.
Yamaji M; Shudo J
Int Immunopharmacol; 2009 Jul; 9(7-8):984-9. PubMed ID: 19362169
[TBL] [Abstract][Full Text] [Related]
30. [Possibilities and limits of chemotherapy of diseases caused by herpes simplex and varicella-zoster virus].
Wassilew SW
Hautarzt; 1983 Jan; 34(1):1-5. PubMed ID: 6841073
[TBL] [Abstract][Full Text] [Related]
31. 3-Hydroxyphthaloyl beta-lactoglobulin. IV Antiviral activity in the mouse model of genital herpesvirus infection.
Kokuba H; Aurelian L; Neurath AR
Antivir Chem Chemother; 1998 Jul; 9(4):353-7. PubMed ID: 9875414
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of virus-encoded thymidine kinase suppresses herpes simplex virus replication in vitro and in vivo.
Watkins AM; Dunford PJ; Moffatt AM; Wong-Kai-In P; Holland MJ; Pole DS; Thomas GM; Martin J; Roberts NA; Mulqueen MJ
Antivir Chem Chemother; 1998 Jan; 9(1):9-18. PubMed ID: 9875372
[TBL] [Abstract][Full Text] [Related]
33. Herpes simplex virus helicase-primase inhibitors are active in animal models of human disease.
Crute JJ; Grygon CA; Hargrave KD; Simoneau B; Faucher AM; Bolger G; Kibler P; Liuzzi M; Cordingley MG
Nat Med; 2002 Apr; 8(4):386-91. PubMed ID: 11927945
[TBL] [Abstract][Full Text] [Related]
34. Protective effect of a natural carrageenan on genital herpes simplex virus infection in mice.
Carlucci MJ; Scolaro LA; Noseda MD; Cerezo AS; Damonte EB
Antiviral Res; 2004 Nov; 64(2):137-41. PubMed ID: 15498610
[TBL] [Abstract][Full Text] [Related]
35. Correlation of in vivo topical efficacies with in vitro predictions using acyclovir formulations in the treatment of cutaneous HSV-1 infections in hairless mice: an evaluation of the predictive value of the C* concept.
Patel PJ; Ghanem AH; Higuchi WI; Srinivasan V; Kern ER
Antiviral Res; 1996 Mar; 29(2-3):279-86. PubMed ID: 8739606
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-12- and gamma interferon-dependent innate immunity are essential and sufficient for long-term survival of passively immunized mice infected with herpes simplex virus type 1.
Vollstedt S; Franchini M; Alber G; Ackermann M; Suter M
J Virol; 2001 Oct; 75(20):9596-600. PubMed ID: 11559791
[TBL] [Abstract][Full Text] [Related]
37. Anti-herpes simplex virus activity of moronic acid purified from Rhus javanica in vitro and in vivo.
Kurokawa M; Basnet P; Ohsugi M; Hozumi T; Kadota S; Namba T; Kawana T; Shiraki K
J Pharmacol Exp Ther; 1999 Apr; 289(1):72-8. PubMed ID: 10086989
[TBL] [Abstract][Full Text] [Related]
38. Herpes simplex virus infections of the central nervous system: encephalitis and meningitis, including Mollaret's.
Tyler KL
Herpes; 2004 Jun; 11 Suppl 2():57A-64A. PubMed ID: 15319091
[TBL] [Abstract][Full Text] [Related]
39. Established latent herpes simplex virus infections of mice not affected by adenosine monophosphate treatment.
Klein RJ
Drugs Exp Clin Res; 1985; 11(12):861-4. PubMed ID: 3836115
[TBL] [Abstract][Full Text] [Related]
40. Acyclovir and vidarabine monophosphate: comparison of iontophoretic and intravenous administration for the treatment of HSV-1 stromal keratitis.
Hill JM; Kwon BS; Burch KD; Deback J; Whang I; Jones GT; Luke B; Harp R; Shimomura Y; Hull DS; Gangarosa LP
Am J Med; 1982 Jul; 73(1A):300-4. PubMed ID: 6179415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
